Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
234.40
-1.64 (-0.69%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Quest Diagnostics Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Quest Diagnostics stock has a consensus rating of "Buy" and an average price target of $245.87. The average 1-year stock price forecast is 4.89% higher than the current stock price, while the lowest is $204 (-12.97%) and the highest is $265 (+13.05%).
Price Target: $245.87 (+4.89%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Quest Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 9 | 9 | 9 | 8 | 7 | 7 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 18 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Argus Research | Argus Research | Buy Maintains $260 | Buy | Maintains | $260 | +10.92% | Jul 29, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $260 | Buy | Maintains | $260 | +10.92% | Jul 29, 2026 |
| Truist Financial | Truist Financial | Hold Maintains $250 | Hold | Maintains | $250 | +6.66% | Jul 29, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Reiterates $220 → $250 | Hold | Reiterates | $220 → $250 | +6.66% | Jul 28, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $265 | Buy | Reiterates | $265 | +13.05% | Jul 24, 2026 |
Financial Forecast
Revenue This Year
12.01B
from 11.04B
Increased by 8.81%
Revenue Next Year
12.57B
from 12.01B
Increased by 4.68%
EPS This Year
11.19
from 9.85
Increased by 13.62%
EPS Next Year
12.06
from 11.19
Increased by 7.74%
EPS and Forward PE are based on non-GAAP adjusted numbers.